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ABSTRACT
Aims To extend the previously identiﬁed association between a single nucleotide polymorphism (SNP) in neuronal
acetylcholine receptor subunit alpha-5 (CHRNA5) and nicotine dependence to current smoking and initial smoking-
experience phenotypes. Design, setting, participants Case–control association study with a community-based
sample, comprising 363 Caucasians and 72 African Americans (203 cases, 232 controls). Measurements Cases had
smoked  ﬁve cigarettes/day for  5 years and had smoked at their current rate for the past 6 months. Controls had
smoked between one and 100 cigarettes in their life-time, but never regularly. Participants also rated, retrospectively,
pleasurable and displeasurable sensations experienced when they ﬁrst smoked. We tested for associations between
smoking phenotypes and the top 25 SNPs tested for association with nicotine dependence in a previous study.
Findings A non-synonymous coding SNP in CHRNA5, rs16969968, was associated with case status [odds ratio
(OR) = 1.5, P = 0.01] and, in Caucasians, with experiencing a pleasurable rush or buzz during the ﬁrst cigarette
(OR = 1.6, P = 0.01); these sensations were associated highly with current smoking (OR = 8.2, P = 0.0001).
Conclusions We replicated the observation that the minor allele of rs16969968 affects smoking behavior, and
extended these ﬁndings to sensitivity to smoking effects upon experimentation. While the ability to test genetic asso-
ciationswaslimitedbysamplesize,thepolymorphismintheCHRNA5subunitwasshowntobeassociatedsigniﬁcantly
withenhancedpleasurableresponsestoinitialcigarettesinregularsmokersinanaprioritest.Theﬁndingssuggestthat
phenotypes related to subjective experiences upon smoking experimentation may mediate the development of nicotine
dependence.
Keywords Case–control design, chromosome 15, early smoking experiences, nicotinic alpha-5 receptor subunit,
single nucleotide polymorphisms (SNPs), smokers and never-smokers.
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INTRODUCTION
The likelihood of initiating and persisting in smoking,
and ultimately of becoming nicotine dependent, are all
inﬂuenced by genetic factors, as demonstrated by numer-
ous twin [1–5], linkage [6–9] and candidate gene
[10–12] studies. Recently, a whole genome association
study by Bierut et al. [13] identiﬁed several common vari-
ants that appear to be associated with nicotine depen-
dence in Caucasians. In that study, which featured
increased single nucleotide polymorphism (SNP) cover-
age in regions containing potential candidate genes,
the most signiﬁcant associations were for SNPs in genes
with functions related to nicotine metabolism and
gamma aminobutyric acid (GABAergic) and glutamater-
gic neurotransmission, showing P-values less than 10-4
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rexin 3 (NRXN3) as well as the neuronal acetylcholine
receptor subunit alpha-5 (CHRNA5) precursor on chro-
mosome 15. A subsequent report by the same group [14]
noted that the alpha 5 polymorphism, rs16969968, a
non-synonymous coding SNP in exon 4 of CHRNA5,
causes an aspartic acid-to-asparagine substitution that
alters the function of the nicotine receptor. The ﬁndings
for the alpha-5 receptor were strengthened by a recent
studybyBerretiniet al.[15],inwhichahighlycorrelated
CHRNA5/CHRNA3 haplotype (cluster of linked genes)
was shown to be associated strongly (P < 10-6) with
smoking behavior (cigarettes smoked per day).
In an attempt to replicate and extend these ﬁndings,
we focused our attention upon phenotype associations
for the top 25 SNPs tested with nicotine dependence
by Bierut et al. Before analysis, we decided to test
rs16969968 a priori, and then examine the other 24
SNPs. Unlike the Bierut et al. study, in which both cases
and controls were smokers, the current study involved a
control group of life-time never-smokers who had taken
at least one puff from a cigarette (to ensure that they had
actively rejected cigarette smoking). Also unlike that
study, our sample included a small, exploratory sample of
African American participants in addition to the larger
sample of Caucasians.
Because recent studies have implicated various nico-
tine receptor subunits in moderating nicotine’s impact
in drug-naive animals [16–18] and in humans [19,20],
we decided to explore possible associations between
rs16969968andphenotypesinvolvingreactivitytociga-
rettes during early smoking experimentation. We were
guided by observations that individuals reporting greater
positive early smoking experiences were more likely to be
regular nicotine-dependent smokers [21–25]. Based on
twin studies suggesting that at least 50% of the variabil-
ity in smoking initiation is attributable to genetic factors
[26,27],wehypothesizedthatsomeof theseeffectsmight
be mediated by variations in nicotine receptor function,
and in particular by the non-synonymous coding SNP
rs16969968.
METHODS
Recruitment
Candidates responding to advertisements in local (Ann
Arbor, MI, USA) newspapers or ﬂyers posted on bulletin
boards around the community were interviewed initially
bytelephoneandaskedabouthealthandsmokinghabits.
Candidates who met preliminary criteria were scheduled
for an individual interview at the University of Michigan
Nicotine Research Laboratory. Cases were recruited ﬁrst
through a parent project of the study—a laboratory
investigation [28] involving administration of nicotine to
current smokers stratiﬁed on nicotine dependence using
theFagerströmTestforNicotineDependence(FTND)[29]
(high dependence: FTND = 4 versus low dependence:
FTND < 4) and on depression using the Center for
Epidemiological Studies–Depression (CES-D) [30] and a
computerized version of the Composite International
Diagnostic Interview (CIDI) [31] [high depression: CES-
D = 16 and/or CIDI life-time diagnosis of major depres-
sive disorder (MDD) versus low depression (CES-D < 16)
and no life-time CIDI diagnosis of MDD]. A supplement
was awarded later to enable the project to join the
National Institute on Drug Addiction (NIDA) Genetics
Consortium and to permit recruitment of never-smokers
who did not participate in the laboratory study but were
otherwise comparable to the smokers; additional current
smokers were also recruited to supplement the core
sample of laboratory participants. Efforts were made to
keep the cells for nicotine dependence (smokers only),
depression and sex approximately equal in size; thus, the
sample was not distributed randomly on these variables.
For all participants, inclusion and exclusion criteria
speciﬁed that candidates be between 25 and 65 years old;
not be currently pregnant or nursing; have no current or
previous diagnosis of psychosis, bipolar disorder, mania
or suicide attempts; have no current (<6 months) use
of psychoactive medication; have no recent consumption
of alcohol beyond speciﬁed limits (15 drinks/week for
women; 21 drinks per week for men) and have no diag-
nosis of alcohol abuse or current illegal drug use.
Case–control deﬁnitions and assessment of early
smoking experiences
Smokers were required to have smoked at least ﬁve
cigarettes/day of  0.5 mg nicotine for  5 years and
had been smoking at their current rate for the past 6
months, indicating current and sustained smoking.
Never smokers were deﬁned as having smoked between
one and 100 cigarettes in their life-time without develop-
ing a pattern of regular smoking.
Early smoking experiences were assessed via the Early
Smoking Experiences Questionnaire (ESE) [21] asking
participants to rate, retrospectively, pleasurable sensa-
tions and unpleasant sensations experienced when they
smoked their ﬁrst cigarette. Pleasurable and unpleasant
sensations (overall), pleasurable rush or buzz, relaxation,
nausea, cough and dizziness were all rated on a scale of 1
(none) to 4 (intense).
Genotyping
This study reports results from genotyping 25 previously
implicated SNPs and 207 ancestrally informative
markers. All samples and Affymetrix Kit Control DNA
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temperature.Eachsample’sconcentrationwasmeasured
using a Nanodrop ND-1000 spectrophotometer (Thermo
Fisher Scientiﬁc, Pittsburgh, PA, USA), and an aliquot
diluted immediately with ddH2Ot o1 5 0mg/ml (18.4 ml)
into a single well of a barcoded 96-well plate. Samples
were processed in this manner sequentially, until all 535
samples were diluted and distributed. Samples were
arranged as 23 samples per plate. Twenty-four plates
were used to accommodate 535 samples and 24 internal
Affymetrix control DNA samples (one per plate), with an
additional 17 wells available for 15 randomly selected
duplicate samples included to measure concordance
rates. All plates were prepared in one afternoon, sealed,
and then frozen at -20°C until processed.
After all 24 plates were processed and scanned, the
overall marker call-rates for each sample were ranked.
[Call-rate is the proportion of genotypes for a given SNP
that can be conﬁdently interrogated, or ‘called’ (e.g. AA,
AB, BB) based on a plot of the raw output from the geno-
typing assays in which genotypic classes are represented
by a cluster of distinct data points.] The 23 poorest per-
forming samples [determined by quality control (QC) call
rate%]wereremoved,stockDNAsthawedanddistributed
onto a ﬁnal plate, and then processed. A total of 598
experimentswereperformedonallsamples,sampledupli-
cates and controls over the entire genotyping effort.
Scanned chip feature intensities were analyzed using the
Affymetrix GeneChipTargeted Genotyping Analysis Soft-
ware (TGAS) package, which normalized the data and
madetheindividualmarkergenotypecallsforallsamples.
Data cleaning and quality control
Inordertoverifyself-reportedancestryandassessadmix-
ture within racial groups, we used the software Structure
version 2.1 [32], which implements a model-based clus-
tering method for inferring population structure using
genotype data for an unlinked subset of the markers
selected because the minor allele frequencies for each
population are characteristic of ancestry. There were 11
participants who self-reported mixed ancestry, reported
their primary ancestry inconsistently or did not report
ancestry. Of the 11 participants in question, one was
excluded for a low QC call rate, ﬁve were determined to
be of mixed heritage (<80% ethnic identity) and were
excluded, and ﬁve were found to exceed the 80% thresh-
oldandwereincluded.Becausethepopulationdeﬁnitions
becamemorestringentwiththeexclusionof participants
with measured admixture, two individuals previously
measured >80% fell below this threshold and were
excluded. Ultimately, 11 Asians, 13 Hispanics and four
people with ambiguous ethnicity were not analyzed
further because of small sample size for these groups.
Three pairs of individuals were found to be related
throughtheprogramRelpairversion2.0.1[33]andwere
determined subsequently to be siblings; in each case, the
one with the most complete data was retained.
Call rates averaged over 97% for all samples, and most
samples were called at 98% or better. Seven of 598
experiments failed to reach the 90% call rate threshold
but only four participant samples failed to reach the 90%
threshold in at least one experiment. These four partici-
pants were removed from further analysis. The concor-
dance rate for the 34 repeated samples (36 experiments;
two samples repeated three times) was 99.3%. Call rates
for individual markers were established by the TGAS
program for call rates over all cases and controls. Call
rates were excellent, with an average call rate of 99.64%
for the genotyped markers including all ancestrally infor-
mative markers (AIMs). Only one AIM failed to achieve
a QC call rate of 90% and was removed from further
analysis. Hardy Weinberg equilibrium (HWE) tests were
carried out to reduce the likelihood of spurious geno-
type associations resulting from technical artifacts from
the genotyping platform. All markers in controls were
deemedtobeinequilibrium(P > 0.01);testswerecarried
out within race groups.
Statistical analysis
SNP–phenotype associations were tested in logistic
regression models implemented in SAS version 9.1.
Genotypic effects were modeled as the additive effect of
the number of minor alleles carried, and adjusted for
raceandgender.Analyseswerealsoperformedseparately
withinthetworacialgroups.Tocontrolformultiplecom-
parisons,wecomputedthefalsediscoveryrate(FDR)[34]
for each of the 25 observed P-values. Brieﬂy, this proce-
dure uses the ranking of the observed P-values, the
number of tests preformed and the hypothesized propor-
tion of true null tests to determine the FDR or Q-value,
deﬁned as the expected proportion of tests called signiﬁ-
cant at a given P-value that would be false positives.
The four-level early smoking experience variables for
each of the sensations were dichotomized into ‘none’ or
‘slight’ versus ‘moderate’ or ‘intense’. Phenotypic data
were analyzed in SAS using c2 and analysis of variance
(ANOVA) as appropriate.
RESULTS
The analyzed sample included 363 Caucasians and 72
African Americans. The 25 most signiﬁcantly associated
SNPs from the Beirut et al. study were typed in this
sampleandanalyzedinbothracialgroups.Table 1shows
participant characteristics and smoking history. For both
cases(regularsmokers)andforcontrols(never-smokers),
1546 Richard Sherva et al.
© 2008 The Authors. Journal compilation © 2008 Society for the Study of Addiction Addiction, 103, 1544–1552Caucasianshadgreateryearsof educationcomparedwith
African American participants. Among cases, number of
cigarettes smoked per day and years of regular smoking
weregreater,andregularsmokingbeganatayoungerage
in Caucasians compared with African Americans.
Table 2 shows smoking-status associations for the 25
top SNPs from the study by Beirut et al. [13], comparing
cases and controls in the present study. As noted earlier,
we decided to ﬁrst test rs16969968 to avoid the need for
multiple testing corrections, and then test the other 24
SNPs. Although the other associations did not achieve
signiﬁcanceaftercorrectionformultipletesting[b=0.40
to detect an odds ratio (OR) of 1.5 for a SNP with a minor
allele frequency (MAF) of 25% at a=0.05 in the com-
bined, race-adjusted sample], P-values for all the SNPs
tested are listed in Table 2 as a guide for further research.
The key ﬁnding is that, after adjustment for gender and
race, rs16969968 was associated signiﬁcantly with
smoking status in Caucasians (OR = 1.51, P = 0.01) and
in Caucasians plus African Americans (combined sample
OR = 1.48, P = 0.01). Although Beirut et al. presented
evidence suggesting that rs16969968 ‘A’ (smoking-risk)
alleles act recessively, signiﬁcant association was based
on genetic effects modeled as the additive effect of minor
alleles in the present study.
The MAF of rs16969968 differed signiﬁcantly be-
tween racial groups, with 174 Caucasians having one
‘A’ allele and 45 having two alleles, while only six African
Americans carried one copy of the ‘A’ allele. Accordingly,
this SNP had a negligible effect on risk of smoking in the
African American sample in the race-stratiﬁed analysis.
Moveover,infourof the25SNPs,majorandminoralleles
were reversed in Caucasians and African Americans.
In addition, minor alleles at rs16969968 were associ-
ated signiﬁcantly with moderate-to-intense pleasurable
rush or buzz in early smoking (OR = 1.6, P = 0.01) in
Caucasians; these sensations in turn were associated
highly with increased risk of current smoking (OR = 8.2,
P < 0.0001). Further, moderate-to-intense pleasurable
rushorbuzzsigniﬁcantlypredictedsmoker/never-smoker
status in a combined, race-adjusted analysis (OR = 6.2,
P < 0.0001). No other initial smoking experience was
associated signiﬁcantly with the rs16969968 genotype.
Table 3 provides further characterization of early-
experience patterns for respondents reporting moderate-
to-intense reactions. Cases (regular smokers) exhibited
enhanced sensitivity to cigarette smoking, with a larger
proportion reporting more positive and more negative
experiences than controls (never-smokers). With respect
to race differences, only global displeasurable and relax-
ation effects reached signiﬁcance in comparisons that
tookintoaccountsmokingstatus;incomparisonslimited
to just smokers, a signiﬁcantly larger proportion of
African Americans endorsed global pleasurable (P <
0.002) and global displeasurable experiences (P <
0.003), along with pleasurable rush or buzz (P < 0.002),
dizziness (P < 0.004), relaxation (P < 0.001) and difﬁ-
culty inhaling (P < 0.02).
Table 1 Participant characteristics and smoking history.
Cases (smokers; n = 203) Controls (never-smokers; n = 232)
c2 or F-test (P-value)
Caucasians African Americans Caucasians African Americans
(n = 155) (n = 48) (n = 208) (n = 24)
Age (years)
(mean  SEM)
38.4  0.84 37.2  1.51 40.2  0.72 34.3  2.14 Status: F = 0.16 (0.6881)
Race: F = 6.15 (0.0135)
S ¥ R*: F = 2.77 (0.0967)
Sex (% female) 48% 35% 55% 63% Status: c
2 = 1.69 (0.1932)
Race: c
2 = 0.45 (0.5015)
S ¥ R*: c2 = 0.22 (0.1364)
Education (years)
(mean  SEM)
14.3  0.16 13.3  0.28 16.3  0.14 15.2  0.40 Status: F = 54.6 (0.0001)
Race: F = 15.14 (0.0001)
S ¥ R*: F = 0.16 (0.6875)
Age 1st try
(mean  SEM)
14.7  0.40 17.1  0.73 15.9  0.36 15.6  1.06 Status: F = 0.07 (0.7888)
Race: F = 2.25 (0.1341)
S ¥ R*: F = 3.78 (0.0524)
No. cigs/day
(mean  SEM)
18.0  0.69 13.7  1.26 Race: F = 8.99 (0.0031)
Age of regular smoking
(mean  SEM)
17.4  0.40 19.5  0.70 Race: F = 6.53 (0.0114)
Years of regular smoking
(mean  SEM)
18.4  0.96 12.8  1.17 Race: F = 8.16 (0.0047)
SEM: standard error of the mean; *S ¥ R: status ¥ race interaction effect.
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The CHRNA5 subunit has been implicated as a potential
riskfactorfornicotinedependence[13]resultingfroman
amino acid variant in a highly conserved region of the
intracellular domain [14]. The present results substanti-
ated these observations and extended the ﬁndings for
dependent and non-dependent smokers in the Bierut
et al. study [13] to nicotine-dependent regular smokers
versusnever-smokers.ArecentreportbyBerretininiet al.
[15] of association between a CHRNA5/CHRNA3 gene
cluster and number of cigarettes smoked per day—a dif-
ferent smoking phenotype—provides further support for
the inﬂuence of the alpha-5 subunit on smoking across
different contrasts. Speciﬁcally, in the Bierut et al. study,
controls were current smokers with FTND scores of zero;
in the Berretinini et al. study, controls were individuals
(both current smokers and never-smokers) consuming
fewer than ﬁve cigarettes per day; in the present study,
controls were never-smokers who had tried at least one
cigarette but had subsequently smoked fewer than 100
cigarettes in their life-time.
Differences in sensitivity to cigarettes during early
experimentationmayhelptoexplainthedisparatetrajec-
tories of individuals who go on to become regular
smokers and those who do not. While our ability to reach
conclusions about genetic associations with all variables
of interest was limited by sample size, the gene-
association analysis in the present study indicates that
minor alleles at rs16969968 may have contributed to
smoking by enhancing the reinforcing effects of nicotine
in nicotine-naive individuals who went on to become
regular smokers. Moreover, smoking-experience analyses
indicate that these effects involved both positive and
negative experiences. Taking into account other recent
studies, the ﬁndings suggest that early smoking experi-
ences may mediate nicotine dependence, involving not
only alpha-5 subunits but possibly also beta-2 subunits
[19]aswellasalpha-6andbeta-3subunits[20].Entrain-
ment of nicotine dependence via enhanced sensitivity to
nicotine also provides a plausible mechanism for explain-
ing ﬁndings from three closely related investigations
showing that risk of smoking and lung cancer is associ-
ated with a group of genes in chromosome 15 coding for
Table 3 Proportion reporting moderate or intense responses (3) to early experimentation with smoking.
Cases (n = 203) Controls (n = 232)
c2 (P-value)
Caucasians African Americans Caucasians African Americans
(n = 155) (n = 48) (n = 208) (n = 24)
Global pleasurable 30% 47% 7% 5% Status: c
2 = 23.2 (0.0001)
Race: c
2 = 0.11 (0.7390)
S ¥ R*: c2 = 0.97 (0.3259)
Global displeasurable 38% 30% 64% 37% Status: c2 = 20.6 (0.0001)
Race: c
2 = 5.11 (0.0238)
S ¥ R*: c2 = 1.55 (0.2131)
Pleasurable rush or buzz 43% 62% 10% 6% Status: c2 = 39.7 (0.0001)
Race: c
2 = 0.32 (0.5730)
S ¥ R*: c
2 = 1.48 (0.2232)
Dizziness 61% 45% 17% 16% Status: c
2 = 56.9 (0.0001)
Race: c
2 = 0.01 (0.9056)
S ¥ R*: c2 = 0.53 (0.4649)
Nausea 28% 20% 18% 11% Status: c2 = 3.91 (0.0479)
Race: c
2 = 0.69 (0.4054)
S ¥ R*: c2 = 0.04 (0.8440)
Relaxation 27% 45% 4% 0% Status: c
2 = 25.5 (0.0001)
Race: c
2 = 25.5 (0.0001)
S ¥ R*: c
2 = 34.87 (0.0001)
Coughing 46% 33% 50% 53% Status: c
2 = 0.54 (0.4628)
Race: c
2 = 0.05 (0.8276)
S ¥ R*: c
2 = 1.06 (0.3038)
Difﬁculty inhaling 48% 31% 58% 47% Status: c
2 = 3.04 (0.0814)
Race: c2 = 0.77 (0.3816)
S ¥ R*: c
2 = 0.22 (0.6392)
*S ¥ R: status ¥ race interaction effect.
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[35–37]. In the aggregate, the nicotine receptor ﬁndings
provide critically needed genotype speciﬁcity for twin
studies, indicating that at least 50% of the variability in
smoking initiation is due to genetic factors [26,27].
The exploration of relationships between smoking
status and early smoking experiences in the African
Americansampleisinconclusiveduetothesmallnumber
of participants available. The following general observa-
tions can be made: in statistical contrasts of race and
smoking status in regular smokers (cases) and controls
(never-smokers), reports of relaxation during early
experimentation with cigarettes were signiﬁcantly
greater in African Americans. Limiting the analysis to
regular smokers provided even stronger support for the
possibility that African Americans may be more reactive
to initial cigarettes than Caucasians (manuscript in
preparation). The fact that allele frequencies for the risk
polymorphism(rs16969968)weresubstantiallylowerin
the African American sample, however, makes it unlikely
that this particular polymorphism can account for diff-
erences between African Americans and Caucasians in
initial sensitivity to cigarettes, but the possibility that
other nicotine receptor subunits (e.g. beta-2, beta-3 or
alpha-6) are involved merits consideration. Systematic
exploration of race differences in susceptibility to
smoking in larger samples has the potential to contribute
important new insights about nicotine dependence
etiology.
The present study utilized retrospective reports of
early experiences with smoking as supplemental pheno-
typic measures. Regular smokers clearly differed from
never-smokersonthesemeasures;moreover,severallines
of evidence suggest that these differences are not attrib-
utable solely to selective recall of positive experiences in
smokers and/or selective recall of negative experiences
in never-smokers. (i) Greater sensitivity to initial ciga-
rettes by people who subsequently become smokers has
been demonstrated in a wide variety of individuals, from
American adults [21] to Chinese adolescents [23]. (ii) As
time from onset of smoking is more recent in adolescents
than adults, demonstration of similarly enhanced sen-
sitivity in young smokers suggests that the early-
experience reports are not merely the result of recall
distortion over time [22–24]. (iii) Systematic examina-
tion of test–retest reliability of subjective reactions to
early smoking [38], including head rush or buzz, led
to the conclusion that reliability was acceptable when
response options are dichotomized (as in the present
study). (iv) Using a period of abstinence to allow for dis-
sipation of tolerance as a model for initial sensitivity,
we found that retrospective reports of head rush or buzz
duringearlyexperimentationwithsmokingpredictedsig-
niﬁcantlywhichindividualsratedre-exposuretonicotine
administered via nasal spray as more pleasurable [25].
(v) Studies of various other aspects of smoking behavior
[38,39] suggest that self-report of tobacco use is gener-
ally reliable.
The genetic ﬁndings of the present study, along with
those of Ehringer et al. [19] and Zeiger et al. [20], impli-
cate initial sensitivity as a key variable in smoking
development[40]andprovidecriticalsupportfortheuse-
fulness of early-experience reports. What is needed next
is the development of real-time assessments of sensitivity
to nicotine based on objective measures [41] that can be
reﬁned and validated ultimately as phenotypes in succes-
sive tests of association with genetic variants.
CONCLUSION
This study provides new information about a genetic risk
factor in the initiation and entrainment of smoking. The
results of the gene-association tests suggest that a poly-
morphismintheCHRNA5subunitmodulatestheexpres-
sion of the initial smoking experience in nicotine-naive
individuals.The ﬁndings suggest that phenotypes related
to early subjective experiences may mediate nicotine
dependence.
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